Explanation
Core Concept
PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM
Step-by-Step Analysis
Cancer arises from accumulated mutations that dismantle the tightly regulated signal transduction networks governing cell proliferation, survival, and programmed cell death. In healthy mammalian cells, receptor tyrosine kinases (RTKs) such as the epidermal growth factor receptor (EGFR) bind extracellular ligands like EGF at specific extracellular domains. This ligand–receptor binding induces dimerization and trans-autophosphorylation of intracellular tyrosine residues, creating docking sites for adaptor proteins containing SH2 domains, including GRB2. The GRB2–SOS complex activates the monomeric GTPase RAS by promoting exchange of GDP for GTP, initiating the MAP kinase cascade (Raf → MEK → ERK). Phosphorylated ERK translocates to the nucleus and activates transcription factors driving expression of cyclin genes, particularly cyclin D, which complexes with CDK4/6 to phosphorylate retinoblastoma protein (Rb). Hyperphosphorylated Rb releases E2F transcription factors, committing the cell to S-phase entry.
Why Other Options Are Wrong
Tumor suppressor mechanisms normally counterbalance these pro-proliferative signals. The p53 protein, stabilized in response to DNA damage or oncogene activation, induces transcription of p21, a CDK inhibitor that halts cell cycle progression at the G1/S checkpoint. Additionally, PTEN dephosphorylates phosphatidylinositol-3,4,5-trisphosphate (PIP3) back to PIP2, antagonizing PI3K/AKT signaling and preventing constitutive survival signals. When mutations convert proto-oncogenes into oncogenes (constitutively active RAS, amplified MYC, or fusion kinases like BCR-ABL) or inactivate tumor suppressors (loss-of-function mutations in TP53, RB1, or PTEN), cells escape normal growth control. These molecular disruptions cascade through the organism: uncontrolled mitotic divisions produce neoplastic masses that compromise tissue architecture, compete for nutrients and oxygen via angiogenic signaling through VEGF, and can metastasize through epithelial-to-mesenchymal transition involving loss of E-cadherin cell–cell adhesion.
PILLAR 2 — STEP-BY-STEP LOGIC
The question stem states that a student observes a change in cancer during an experiment specifically designed around cell communication. This experimental context is essential: the investigator is deliberately manipulating or monitoring signaling pathways. Any observed alteration in cancer phenotype during such an experiment reflects the mechanistic relationship between signal transduction fidelity and oncogenic transformation. The cancer change observed—whether increased proliferation, reduced apoptosis, enhanced motility, or altered morphology—represents a measurable disruption in the molecular circuitry that normally constrains cellular behavior.
Option A correctly synthesizes this relationship: the observed change in cancer constitutes a disruption in normal cellular function (dysregulated signal transduction, compromised cell cycle checkpoints, or defective apoptosis). The phrase "may affect the organism" acknowledges the hierarchical nature of biological organization. A single cellsignaling defect at the molecular level propagates through tissue-level consequences (tumor formation, invasion of adjacent structures) to organismal-level harm (organ failure, metabolic dysregulation, cachexia, metastatic spread to liver, lungs, bone, or brain). The modal verb "may" reflects appropriate scientific caution; not every cellular perturbation produces organismal consequences, as DNA repair mechanisms, immune surveillance by cytotoxic T lymphocytes and natural killer cells, and compensatory pathways can sometimes mitigate localized damage.
PILLAR 3 — DISTRACTOR ANALYSIS
Option B traps students who confuse stochastic variation in experimental measurements with biologically meaningless noise. While individual molecular events (a single base substitution, one aberrant phosphorylation) may involve random components, the phenotypic change in cancer is the integrated output of deterministic biochemical pathways. Dismissing the observation as "no biological significance" ignores that cancer is defined by functional consequences—sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, and replicative immortality. A student selecting B fails to connect genotype-level mutations to phenotype-level cellular transformation through defined signaling cascades.
Option C exploits the misconception that experimental conditions are artificial constructs disconnected from biological reality. This reasoning reflects a fundamental misunderstanding of experimental design. Researchers manipulate variables precisely because those variables map onto genuine physiological mechanisms. An experiment testing the effect of a VEGF receptor inhibitor on cancer angiogenesis, for example, directly models the therapeutic targeting of paracrine signaling pathways that tumors co-opt for vascularization. Declaring the conditions "irrelevant to the system" would invalidate the entire methodology of cell biology, pharmacology, and translational medicine.
Option D represents the most dangerous conceptual error: severing the established mechanistic link between cell communication and oncogenesis. Decades of research have demonstrated that cancer is fundamentally a disease of dysregulated communication—whether autocrine loops (tumor cells secreting and responding to their own growth factors), paracrine hijacking (secreting factors that remodel the tumor microenvironment), or juxtacrine disruption (altered Notch receptor–ligand interactions between adjacent cells). The six hallmarks of cancer articulated by Hanahan and Weinberg all depend on corrupted information processing within and between cells. A student choosing D has failed to recognize that cell communication is not merely correlated with cancer but is the very substrate upon which oncogenic transformation operates.
Correct Answer
BThe change indicates a disruption in normal cellular function that may affect the organism
Practice more AP Biology questions with AI-powered explanations
Practice Unit 4: Cell Communication and Cell Cycle Questions →